- Home
- SXTP vs GLMD Comparison
SXTP vs GLMD Comparison
Compare SXTP & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | GLMD |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | United States | Israel |
| Employees | 3 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.2M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | SXTP | GLMD |
|---|---|---|
| Price | $1.50 | $0.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.10 | N/A |
| AVG Volume (30 Days) | 44.1K | ★ 192.2K |
| Earning Date | 05-15-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.92 | N/A |
| Revenue Next Year | $51.35 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $0.41 |
| 52 Week High | $8.62 | $1.80 |
Technical Indicators
Market Signals| Indicator | SXTP | GLMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 46.21 |
| Support Level | $1.29 | $0.41 |
| Resistance Level | $1.59 | $0.70 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 52.38 | 40.46 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.